WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010031712) MEANS AND METHODS FOR DIAGNOSING PREDISPOSITION FOR TREATMENT EMERGENT SUICIDAL IDEATION (TESI)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/031712    International Application No.:    PCT/EP2009/061575
Publication Date: 25.03.2010 International Filing Date: 07.09.2009
IPC:
C12Q 1/68 (2006.01)
Applicants: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. [DE/DE]; Hofgartenstr. 8 80539 München (DE) (For All Designated States Except US).
MENKE, Andreas [DE/DE]; (DE) (For US Only).
BINDER, Elisabeth, B. [DE/DE]; (DE) (For US Only).
HOLSBOER, Florian [DE/DE]; (DE) (For US Only)
Inventors: MENKE, Andreas; (DE).
BINDER, Elisabeth, B.; (DE).
HOLSBOER, Florian; (DE)
Agent: VOSSIUS & PARTNER; Siebertstraße 4 81675 München (DE)
Priority Data:
08016477.5 18.09.2008 EP
09003639.3 12.03.2009 EP
Title (EN) MEANS AND METHODS FOR DIAGNOSING PREDISPOSITION FOR TREATMENT EMERGENT SUICIDAL IDEATION (TESI)
(FR) MOYENS ET PROCÉDÉS POUR DIAGNOSTIQUER UNE PRÉDISPOSITION À UNE IDÉATION SUICIDAIRE CONSÉCUTIVE À UN TRAITEMENT (TESI)
Abstract: front page image
(EN)This invention relates to a method of diagnosing a predisposition for or the occurrence of treatment emergent suicidal ideation in an individual, the method comprising determining the presence or absence of one, more or all SNPs selected from the SNPs defined by SEQ ID NOs: 8, 18, 19, 47, 50, 52, 56, 64, 73, 86, 87, 92, 94, 95, 97 and 99.
(FR)La présente invention concerne un procédé de diagnostic d’une prédisposition à ou de l’occurrence d’une idéation suicidaire consécutive à un traitement chez un individu, le procédé comprenant la détermination de la présence ou de l’absence d’un, plusieurs ou tous les SNP choisis parmi les SNP définis par SEQ ID NO: 8, 18, 19, 47, 50, 52, 56, 64, 73, 86, 87, 92, 94, 95, 97 et 99.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)